Availability, Management and Use of Priority Life-Saving Medicines for Under-Five Children in Two Health Districts in Senegal: A Cross-Sectional Study — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Availability, Management and Use of Priority Life-Saving Medicines for Under-Five Children in Two Health Districts in Senegal: A Cross-Sectional Study
Department of Preventive Medicine and Public Health, Faculty of Medicine, Pharmacy and Odontology, Cheikh Anta Diop University, Dakar, Senegal
,
University Service of Pediatrics, Faculty of Medicine, Pharmacy and Odontology, Cheikh Anta Diop University, Dakar, Senegal
,
Department of Community Health, Alioune Diop University, Bambey, Senegal
,
Faculty of Medicine, Pharmacy and Odontology, Cheikh Anta Diop University, Dakar, Senegal
,
Institute of Health and Development, Cheikh Anta Diop University, Dakar, Senegal
,
Institute of Health and Development, Cheikh Anta Diop University, Dakar, Senegal
,
Institute of Health and Development, Cheikh Anta Diop University, Dakar, Senegal
,
National Hospital Center Dalal Jam, Dakar, Senegal
1 Department of Preventive Medicine and Public Health, Faculty of Medicine, Pharmacy and Odontology, Cheikh Anta Diop University, Dakar, Senegal
2 University Service of Pediatrics, Faculty of Medicine, Pharmacy and Odontology, Cheikh Anta Diop University, Dakar, Senegal
3 Department of Community Health, Alioune Diop University, Bambey, Senegal
4 Faculty of Medicine, Pharmacy and Odontology, Cheikh Anta Diop University, Dakar, Senegal
5 Institute of Health and Development, Cheikh Anta Diop University, Dakar, Senegal
6 Institute of Health and Development, Cheikh Anta Diop University, Dakar, Senegal
7 Institute of Health and Development, Cheikh Anta Diop University, Dakar, Senegal
8 National Hospital Center Dalal Jam, Dakar, Senegal
Under-five mortality remains a major concern in the world and in Senegal. It is mainly due to preventable and treatable diseases with priority life-saving medicines for under-five children. This study evaluated the availability, management and use of these drugs in two health districts in Senegal. A descriptive cross-sectional study was conducted in the health districts of Guediawaye and Pete from 01 November 2018 to 31 January 2019. The health district of Guediawaye is in the region hosting the Senegalese capital while that of Pete is located in the region of Saint Louis, northern Senegal. Nine drugs that can prevent and treat malaria, diarrhea, pneumonia and malnutrition were selected. An inventory form and a self-administered questionnaire were used to collect data that was analyzed with SPSS and expressed as a percentage and average. Drug availability was 50.4% and 54.3% in Guediawaye and in Pete, respectively. Average stock-out duration in the past three months was estimated at 22.6 and 26 days, respectively. The drug management was marked, on the one hand, by a good availability of stock cards in the two districts with proportions equal to 100% and 94.1%, respectively, and on the other hand, by the presence of expired stocks in Pete (12.2%). About 79% and 88% of prescribers reported prescribing the basket drug, respectively. These results show that access to priority life-saving medicines for children remains a challenge. Measures to be taken should include improving the distribution channels and training of health professionals. Further studies should be conducted in other health districts to better understand the barriers to access to child health services.
United Nations Inter-Agency Group for Child Mortality Estimation (2018) Levels & Trend in Child Mortality [Internet]. The United Nations Children’s Fund, New York. https://childmortality.org/wp-content/uploads/2018/12/UN-IGME-Child-Mortality-Report-2018.pdf
Agence Nationale de la Statistique et de la Démographie (2018) Enquête Démographique et de Santé Continue [Internet]. ANSD et ICF, Dakar. http://dhsprogram.com/pubs/pdf/FR345/FR345.pdf
Fonds des Nations Unies pour l’Enfance (2016) La situation des enfants dans le monde: L’égalité des chances pour chaque enfant [Internet]. UNICEF, New York. https://www.unicef.org/french/publications/files/UNICEF_SOWC_2016_French_LAST.pdf
Swain, T.R., Rath, B., Dehury, S., Tarai, A., Das, P., Samal, R., et al. (2015) Pricing and Availability of Some Essential Child Specific Medicines in Odisha. Indian Journal of Pharmacology, 47, 496-501. https://doi.org/10.4103/0253-7613.165197
Liu, L., Oza, S., Hogan, D., Chu, Y., Perin, J., Zhu, J., et al. (2016) Global, Regional, and National Causes of Under-5 Mortality in 2000-15: An Updated Systematic Analysis with Implications for the Sustainable Development Goals. The Lancet, 388, 3027-3035. https://doi.org/10.1016/S0140-6736(16)31593-8
Organisation Mondiale de la Santé (2015) La stratégie mondiale pour la santé de la femme, de l’enfant et de l’adolescent (2016-2030) [Internet]. OMS, Genéve. https://www.who.int/maternal_child_adolescent/documents/strategie-mondiale-femme-enfant-ado-2016-2030.pdf
Organisation Mondiale de la Santé (2012) Médicaments vitaux prioritaires destinés aux mères et aux enfants [Internet]. OMS, Genéve. http://apps.who.int/medicinedocs/documents/s19895fr/s19895fr.pdf
Sado, E. and Sufa, A. (2016) Availability and Affordability of Essential Medicines for Children in the Western Part of Ethiopia: Implication for Access. BMC Pediatrics, 16, Article No. 40. https://doi.org/10.1186/s12887-016-0572-3
Anson, A., Ramay, B., de Esparza, A.R. and Bero, L. (2012) Availability, Prices and Affordability of the World Health Organization’s Essential Medicines for Children in Guatemala. Global Health, 8, 22. https://doi.org/10.1186/1744-8603-8-22
Organisation Mondiale de la Santé (2011) Médicaments prioritaires destinés aux mères et aux enfants [Internet]. OMS, Genéve. https://www.who.int/medicines/publications/frA4prioritymedicines.pdf
Kade, K., Kingshott, E., Latimer, A., Nieuwenhuyus, B.J., Pacque, M., Fox, S., et al. (2013) Mise à l’échelle de l’usage des produits d’importance vitale pour les femmes, les enfants et les nouveaux-nés. Une boite à outils pour le plaidoyer. PATH, Washington DC.
Hill, S., Yang, A. and Bero, L. (2012) Priority Medicines for Maternal and Child Health: A Global Survey of National Essential Medicines Lists. PLoS ONE, 7, e38055. https://doi.org/10.1371/journal.pone.0038055
Ministère de la Santé et de la Prévention Médicale (2006) Politique Pharmaceutique Nationale [Internet]. MSPM, Dakar. http://apps.who.int/medicinedocs/documents/s18820fr/s18820fr.pdf
Ministere de la Santé et de l’Action sociale (2018) Liste Nationale des Médicaments et Produits Essentiels du Sénégal [Internet]. MSAS, Dakar. https://www.dirpharm.net/images/sampledata/pdf/Liste_nationale.pdf
Ministere de la Santé et de l’Action Sociale (2014) Bulletin d’information pharmaceutique-Trimestriel numéro 3 [Internet]. MSAS, Dakar. https://www.dirpharm.net/index.php/legislation/textes-legislatifs/category/2-bulletin-d-information
Organisation Mondiale de la santé, Health Action Internationale (2008) Mesurer les prix, l’accessibilité financière et les composantes des prix des médicaments [Internet]. OMS, Genève. https://haiweb.org/wp-content/uploads/2015/07/Table-of-Contents-FR-Measuring-Medicine-Prices-Methodology.pdf
Robertson, J., Forte, G., Trapsida, J.-M. and Hill, S. (2009) What Essential Medicines for Children Are on the Shelf? Bulletin of the World Health Organization, 87, 231-237. https://doi.org/10.2471/BLT.08.053645
Alefan, Q., Amairi, R. and Tawalbeh, S. (2018) Availability, Prices and Affordability of Selected Essential Medicines in Jordan: A National Survey. BMC Health Services Research, 18, Article No. 787. https://doi.org/10.1186/s12913-018-3593-9
Agence Nationale de Statistique et de la Démographie (2018) Enquête Continue sur la Prestation des Services de Soins de Santé (ECPSS) 2017 [Internet]. ANSD et ICF, Dakar. http://dhsprogram.com/pubs/pdf/SPA27/SPA27.pdf
Ministère de la Santé et de l’Action Sociale. Système d’information sanitaire/MSAS [Internet]. https://senegal.dhis2.org/dhis/dhis-web-commons/security/login.action
Ministère de la Santé et de l’Action Sociale (2018) Cartographie du district sanitaire de Pété. MSAS-RM-DS Pété, Pété.
Abrha, S., Tadesse, E., Atey, T.M., Molla, F., Melkam, W., Masresha, B., et al. (2018) Availability and Affordability of Priority Life-Saving Medicines for Under-Five Children in Health Facilities of Tigray Region, Northern Ethiopia. BMC Pregnancy Childbirth, 18, 1-9. https://doi.org/10.1186/s12884-018-2109-2
Nsabagasani, X., Ogwal-Okeng, J., Mbonye, A., Ssengooba, F., Muhumuza, S. and Hansen, E.H. (2015) Availability and Utilization of the WHO Recommended Priority Lifesaving Medicines for under Five-Year Old Children in Public Health Facilities in Uganda: A Cross-Sectional Survey. Journal of Pharmaceutical Policy and Practice, 8, 1-7. https://doi.org/10.1186/s40545-015-0038-2
Organisation Mondiale de la Santé (1996) Indicateurs de suivi de la mise en aeuvre des politiques pharmaceutiques nationales [Internet]. OMS, Généve. https://apps.who.int/medicinedocs/pdf/whozip15f/whozip15f.pdf
Ministère de la Santé (2013) Rapport d’enquête sur les services de sante Disponibilité et capacité opérationnelle des services de santé au Bénin [Internet]. MS, Cotonou. https://www.who.int/healthinfo/systems/SARA_Benin_2013_fullreport.pdf
Organisation mondiale de la Santé (2015) Mesurer la disponibilité et la capacité opérationnelle des services (SARA): Un outil d’évaluation des établissements de santé: Manuel de référence, version 2.2, Révision Juillet 2015 [Internet]. OMS, Généve. https://apps.who.int/iris/bitstream/handle/10665/149026/WHO_HIS_HSI_2014.5_fre.pdf?sequence=1&isAllowed=y
Campbell, H., el Arifeen, S., Hazir, T., O’Kelly, J., Bryce, J., Rudan, I., et al. (2013) Measuring Coverage in MNCH: Challenges in Monitoring the Proportion of Young Children with Pneumonia Who Receive Antibiotic Treatment. PLOS Medicine, 10, e1001421. https://doi.org/10.1371/journal.pmed.1001421
Hendricks, M., Beardsley, J., Bourne, L., Mzamo, B. and Golden, B. (2007) Are Opportunities for Vitamin A Supplementation Being Utilised at Primary Health-Care Clinics in the Western Cape Province of South Africa? Public Health Nutrition, 10, 1082-1088. https://doi.org/10.1017/S1368980007699522
Berde, A.S., Bester, P. and Kruger, I.M. (2019) Coverage and Factors Associated with Vitamin A Supplementation among Children Aged 6-59 Months in Twenty-Three Sub-Saharan African Countries. Public Health Nutrition, 22, 1770-1776. https://doi.org/10.1017/S1368980018004056
Horton, S., Blum, L.S., Diouf, M., Ndiaye, B., Ndoye, F., Niang, K., et al. (2018) Delivering Vitamin A Supplements to Children Aged 6-59 Months: Comparing Delivery through Campaigns and through Routine Health Services in Senegal. Current Developments in Nutrition, 2, nzy006. https://doi.org/10.1093/cdn/nzy006
Berger, R., Courtright, P. and Barrows, J. (1995) Vitamin A Capsule Supplementation in Malawi Villages: Missed Opportunities and Possible Interventions. American Journal of Public Health, 85, 718-719. https://doi.org/10.2105/AJPH.85.5.718
Ministère de la Santé et de l’Action Sociale (2017) Bulletin épidémiologique du paludisme au Sénégal [Internet]. MSAS, Dakar. http://www.pnlp.sn/wp-content/uploads/2017/12/Bulletin-Epidemiologique-du-Paludisme-au-SENEGAL-Trimestriel-N%C2%B003_2017-vf.pdf
Organisation Mondiale de la Santé (2017) Traitement de pré transfert du paludisme grave avec de l’artésunate par voie rectale [Internet]. Genève. https://apps.who.int/iris/bitstream/handle/10665/259484/WHO-HTM-GMP-2017.19-fre.pdf;jsessionid=6EE46B073BB440FF30F43B5F5434B510?sequence=1
Frost, A., Wilkinson, M., Boyle, P., Patel, P. and Sullivan, R. (2016) An Assessment of the Barriers to Accessing the Basic Package of Health Services (BPHS) in Afghanistan: Was the BPHS a Success? Global Health, 12, 71. https://doi.org/10.1186/s12992-016-0212-6
Organisation Mondiale de la Santé (2014) Accès aux médicaments essentiels-Rapport du Secrétariat [Internet]. Genève. https://apps.who.int/iris/bitstream/handle/10665/170818/A67_30-fr.pdf?sequence=1&isAllowed=y
Mikkelsen-Lopez, I., Tediosi, F., Abdallah, G., Njozi, M., Amuri, B., Khatib, R., et al. (2013) Beyond Antimalarial Stock-Outs: Implications of Health Provider Compliance on Out-of-Pocket Expenditure during Care-Seeking for Fever in South East Tanzania. BMC Health Services Research, 13, Article No. 444. https://doi.org/10.1186/1472-6963-13-444
Barbereau, S. (2013) L’approvisionnement en médicaments dans les pays en voie de développement-Il faut sauver les centrales d’achats publiques de médicaments en Afrique. Médecine et Santé Tropicales, 23, 251-255.
Ottino, G., Lebel, D., Bussières, J.F. and Bourdon, O. (2012) Gestion des ruptures d’approvisionnement de médicaments: Perspectives en France, aux Etats-Unis et au Canada. The Canadian Journal of Hospital Pharmacy, 65, 37-42. https://doi.org/10.4212/cjhp.v65i1.1102
Briggs, J., Embrey, M., Maliqi, B., Hedman, L. and Requejo, J. (2018) How to Assure Access of Essential RMNCH Medicines by Looking at Policy and Systems Factors: An Analysis of Countdown to 2015 Countries. BMC Health Services Research, 18, Article No. 952. https://doi.org/10.1186/s12913-018-3766-6
Ministère de la Sante, des Affaires Sociales et de la Famille. Manuel de gestion des médicaments dans les centres de sante intégrés et hopitaux de référence [Internet]. MSASF, Brazaville. http://afrolib.afro.who.int/documents/2009/fr/Cg-GestionMedicaments.pdf
De Solère, M. (2012) Accessibilité aux médicaments en Afrique de l’ouest: Problématique de la prise en charge des médicaments périmés dans le secteur pharmaceutique public. étude de cas par PSF37 au Bénin [Thesis]. [Rouen]: U.F.R de Médecine et de Pharmacie de Rouen, 185 p.
Organisation Mondiale de la Santé (2018) étude de l’impact socioéconomique et sur la santé publique des produits médicaux de qualité inférieure et falsifiés [Internet]. OMS, Genève. http://dirpharm.sn/pdf/ProduitsMedicauxFalsifieesOMS.pdf
Paut Kusturica, M., Tomas, A. and Sabo, A. (2017) Disposal of Unused Drugs: Knowledge and Behavior among People around the World. Reviews of Environmental Contamination and Toxicology, 240, 71-104. https://doi.org/10.1007/398_2016_3
Ministère de la Santé et de l’Action Sociale (2014) Fiche de notification d’effet indesirable susceptible d’etre du a un medicament ou a un autre produit de sante [Internet]. Dakar. http://www.dirpharm.net/images/sampledata/pdf/FicheNotificationSystemeNationalPV2014.pdf
Ministère de la Santé et de l’Action Sociale. Fiche de signalement d’un médicament suspecté d’un défaut de qualité pouvant entrainer un risque pour la santé/sécurité du patient [Internet]. MSAS, Dakar. http://www.dirpharm.net/images/sampledata/pdf/fiche_signalement.pdf
Ministère de la Santé et de l’Action Sociale (2014) Guide du formateur de l’acteur communautaire de soins sur les maladies prioritaires de l’enfant [Internet]. MSAS, Dakar. http://www.pnlp.sn/wp-content/uploads/2018/02/AIDE-MEMOIRE-DSDOM.pdf